TrialNature communications2025

Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial.

Jyoti Mayadev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.